Stay updated on XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial
Sign up to get notified when there's something new on the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page.

Latest updates to the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision label v3.4.2 has been added. The previously displayed government funding status notice (and the earlier v3.4.1 revision) has been removed.SummaryDifference0.5%

- Check20 days agoChange DetectedA government funding notice banner was added, and the site revision tag was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check28 days agoChange DetectedAdded a 'Show glossary' option and updated some metadata labels (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data') along with a new revision note 'Revision: v3.4.0'; the previous labels ('Last Update Submitted that met QC Criteria' and 'No FEAR Act data') and prior revision note 'Revision: v3.3.4' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now lists Revision: v3.3.4 and no longer shows Revision: v3.3.3.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a Locations section with Massachusetts as a study site and updated the page revision to v3.3.3. Removed HHS Vulnerability Disclosure and several related topics (including MedlinePlus Genetics and Massachusetts Locations) from the page.SummaryDifference0.4%

- Check71 days agoChange DetectedAdded Prostate cancer and related topics: MedlinePlus Genetics to the study page to improve context and navigation.SummaryDifference0.2%

Stay in the know with updates to XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page.